Smart contact lens study for Stargardt's disease
Part of Eyes & vision, Genetic & congenital clinical trials.
This study tests whether a smart contact lens is comfortable and safe to wear. It includes people with Stargardt's disease (a genetic eye condition) and healthy volunteers to see how well the lens works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have Stargardt's disease with decreased vision, or you are a healthy volunteer matched by age and sex
- You can see at least 20/400 (with glasses or contacts) if you have Stargardt's, or 20/20 if healthy
- You do not have other eye diseases like severe dry eye or keratoconus
- You are not allergic to the lens material or the eye drops used in the study
- You can speak French well enough to understand instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with Stargardt disease (a genetic eye condition that causes vision loss) over time. It aims to learn more about how the disease progresses and does not test any treatment.
This study tests a new way to measure vision, called MLSDT, in people with normal sight or vision loss from Stargardt disease or geographic atrophy (a type of advanced age-related macular degeneration). Results will help doctors better understand how well patients can see.
This trial tests a new gene therapy called SB-007 for people with Stargardt disease (STGD1). It is given as an injection under the retina to see if it is safe and can help slow vision loss.
This trial tests a single injection of a new medicine, RTx-021, into the eye for people with Stargardt disease. The goal is to see if it is safe and to find the right dose.
This study will check if certain vision tests work well in people with retinal diseases like retinitis pigmentosa or Stargardt. Results will help design future trials.
This study observes how Stargardt disease and similar eye conditions change over time in children and adults. It aims to learn more about the disease progression to help develop future treatments.
Hear when a new Stargardt Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.